-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Jazz Pharmaceuticals plc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
- Jazz Pharmaceuticals plc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $56.7M, a 7.78% decline year-over-year.
- Jazz Pharmaceuticals plc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $227M, a 3.76% decline year-over-year.
- Jazz Pharmaceuticals plc annual Share-based Payment Arrangement, Expense for 2023 was $227M, a 2.18% increase from 2022.
- Jazz Pharmaceuticals plc annual Share-based Payment Arrangement, Expense for 2022 was $222M, a 17.5% increase from 2021.
- Jazz Pharmaceuticals plc annual Share-based Payment Arrangement, Expense for 2021 was $189M, a 56.2% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)